<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Kidney transplantation in adults: Timing of transplantation and issues related to dialysis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Kidney transplantation in adults: Timing of transplantation and issues related to dialysis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Kidney transplantation in adults: Timing of transplantation and issues related to dialysis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel C Brennan, MD, FACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brent W Miller, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John Vella, MD, FACP, FRCP, FASN, FAST</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane C Tan, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 21, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients who receive a kidney transplant generally have decreased mortality compared with patients who are on dialysis. (See  <a class="medical medical_review" href="/z/d/html/7347.html" rel="external">"Kidney transplantation in adults: Patient survival after kidney transplantation"</a>.)</p><p>Preemptive transplantation, defined as elective transplantation prior to the requirement for chronic dialysis, allows the patient to avoid dialysis completely. Preemptive transplantation improves patient survival compared with transplantation after initiation of dialysis. However, dialysis is often required by patients who are awaiting transplantation or who receive a transplant that does not work immediately.</p><p>This topic review discusses the timing of kidney transplantation and the optimal dialysis modality and prescription for patients who require dialysis either before or after transplantation. Dialysis issues in the patient with a failed kidney transplant are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7320.html" rel="external">"Kidney transplantation in adults: Management of the patient with a failed kidney transplant"</a>.)</p><p class="headingAnchor" id="H63438807"><span class="h1">TIMING OF TRANSPLANTATION</span></p><p class="headingAnchor" id="H2018112384"><span class="h2">Patients not on dialysis</span></p><p class="headingAnchor" id="H1897839493"><span class="h3">Preemptive transplantation</span><span class="headingEndMark"> — </span>Preemptive transplantation is defined as elective transplantation prior to the initiation of chronic dialysis. For most patients with end-stage kidney disease (ESKD) who are suitable candidates for transplantation, we suggest preemptive transplantation rather than waiting until dialysis is initiated. The suitability of individuals for transplantation is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7309.html" rel="external">"Kidney transplantation in adults: Evaluation of the potential kidney transplant recipient"</a>.)</p><p>Exceptions to universal preemptive transplantation include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have severe, symptomatic nephrotic syndrome. Severely nephrotic patients are hypercoagulable and may be at increased risk for thrombosis of the allograft or deep vein thrombosis and pulmonary emboli. Such patients may benefit from dialysis prior to transplantation, with the expectation that residual kidney function, and thus nephrosis, will decline significantly. Dialysis tends to decrease the thrombotic tendency associated with nephrotic syndrome. However, there is no high-quality evidence to support this approach. Thus, an individualized decision should be made, with careful attention paid to patients who have a prior history of venous thrombosis. The optimal method to decrease severe nephrosis before kidney transplantation (eg, nephrectomy, embolization, or medical nephrectomy) remains unclear. (See  <a class="medical medical_review" href="/z/d/html/3043.html" rel="external">"Hypercoagulability in nephrotic syndrome", section on 'Pathogenesis'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are undergoing a second transplant after the first transplanted kidney has failed within one year from transplantation. Such patients may benefit from a short period of dialysis prior to transplantation, as discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7320.html" rel="external">"Kidney transplantation in adults: Management of the patient with a failed kidney transplant", section on 'Retransplantation'</a>.)</p><p></p><p>Preemptive transplantation is generally preferred because it leads to substantial improvements in graft and patient survival when compared with transplantation after a period of dialysis therapy [<a href="#rid1">1-4</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of nearly 40,000 primary kidney transplant recipients, those undergoing preemptive transplantation had 25 and 27 percent reductions in the relative risk for graft loss for deceased- and living-donor transplants, respectively [<a href="#rid1">1</a>]. Corresponding risks for patient death were reduced by 16 and 31 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an analysis of 7948 patients identified from the Dutch National Organ Transplant Registry, the 10-year survival was greater among patients who underwent a preemptive living-donor kidney transplant compared with patients who had a deceased-donor transplantation after a median time of three years on dialysis (73 versus 45 percent, respectively) [<a href="#rid5">5</a>]. Compared with waitlisting on dialysis, the survival benefit with preemptive transplantation was approximately 7.5 to 9.9 years for 40-year-old patients and 4.3 to 6 years for 70-year-old patients.</p><p></p><p>The amount of time that a patient spends on dialysis prior to transplantation is directly related to increased mortality, suggesting a dose-dependent effect of dialysis. (See <a class="local">'Patients already on dialysis'</a> below.)</p><p>Improved graft and patient survival associated with preemptive transplantation may be related to decreased rates of delayed graft function and biopsy-confirmed acute rejection for both deceased-donor and living-donor transplants [<a href="#rid2">2,3,6</a>]. In addition, relatively lower clearance provided by dialysis, compared with a transplanted kidney, may cause the accumulation of substances associated with atherosclerosis, malnutrition, and chronic inflammation [<a href="#rid7">7</a>].</p><p>In general, patients undergoing preemptive transplantation are also likely to be more educated, come from a higher socioeconomic background, and be followed by a nephrologist earlier in the course of their chronic kidney disease (CKD), all factors that have been shown to confer better outcomes posttransplantation. This has been further highlighted by new payment models in the United States that reward or penalize nephrologist performance in preemptive kidney transplantation in the Advancing American Kidney Health initiative [<a href="#rid8">8</a>]. </p><p>Despite the demonstrated benefit of preemptive kidney transplantation, only 20 percent of living-donor and 5 percent of deceased-donor transplants are performed preemptively in the United States [<a href="#rid9">9</a>]. This is primarily due to the rapid increase in the number of potential transplant candidates without a commensurate increase in the donor pool. As a result, the waiting time for a deceased-donor kidney has dramatically increased over the last 15 years.</p><p class="headingAnchor" id="H63436591"><span class="h3">Glomerular filtration rate threshold for transplantation</span><span class="headingEndMark"> — </span>Although we believe that transplantation should be performed in most patients prior to the need for dialysis, the precise level of kidney function (ie, glomerular filtration rate [GFR]) at which to perform a transplant is not known.</p><p>Experts generally agree that transplantation should not be performed until the estimated GFR (eGFR) is &lt;20 mL/min/1.73 m<sup>2</sup> with evidence of a progressive and irreversible decrease in kidney function over the previous 6 to 12 months. In the United States, United Network for Organ Sharing (UNOS) rules dictate that the eGFR needs to be 20 mL/min/1.73 m<sup>2</sup> or less prior to preemptive transplantation. This is consistent with the consensus guidelines from the Canadian Society of Transplantation [<a href="#rid10">10</a>]. We calculate the eGFR using the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation (<a class="calc calc_professional" href="/z/d/html/15635.html" rel="external">calculator 1</a>). (See  <a class="medical medical_review" href="/z/d/html/2359.html" rel="external">"Assessment of kidney function"</a>.)</p><p>Performing kidney transplantation at a higher eGFR is <strong>not</strong> justified, even in the setting of irreversible kidney disease. This is because patients generally have few signs or symptoms of ESKD that require dialysis at this level of kidney function, and there is no benefit to be gained by performing a transplantation before it is required [<a href="#rid11">11,12</a>]. This was best shown by an analysis of 19,461 first-time, preemptive kidney transplant recipients reported to UNOS between 1995 and 2009 [<a href="#rid12">12</a>]. Analysis of this large cohort did not detect any difference in patient survival or death-censored graft survival among patients who were transplanted at eGFRs &lt;10, between 10 and 15, between 15 and 20, and &gt;20 mL/min/1.73 m<sup>2</sup>, respectively.</p><p>Once the eGFR is below 20 mL/min/1.73 m<sup>2</sup>, the decision to perform an elective preemptive transplant should be based upon individual patient (and donor) preferences. Unlike the decision to initiate chronic dialysis, the transplant should not be delayed until the emergence of uremic symptoms. (See  <a class="medical medical_review" href="/z/d/html/1866.html" rel="external">"Indications for initiation of dialysis in chronic kidney disease"</a>.)</p><p>Referral for evaluation by a transplant team should take place before this eGFR is reached, as the process from initial encounter to either preemptive transplantation or deceased-donor listing can approach 6 to 12 months in many centers. We refer patients for transplant evaluation with a diagnosis of progressive CKD and an eGFR &lt;30 mL/min/1.73 m<sup>2</sup>. (See  <a class="medical medical_review" href="/z/d/html/7309.html" rel="external">"Kidney transplantation in adults: Evaluation of the potential kidney transplant recipient", section on 'Timing of referral'</a>.)</p><p class="headingAnchor" id="H22706301"><span class="h2">Patients already on dialysis</span><span class="headingEndMark"> — </span>Patients who are already on dialysis and are suitable candidates for transplantation should be considered for transplantation as soon as possible. This is because the adverse effects of dialysis therapy on posttransplant outcomes are duration dependent. As noted above, transplantation is associated with better outcomes than dialysis for most patients. With approximately 17 percent of the United States' prevalent patients on dialysis in 2022 on a transplant waiting list, more opportunities exist [<a href="#rid13">13,14</a>]. (See  <a class="medical medical_review" href="/z/d/html/7347.html" rel="external">"Kidney transplantation in adults: Patient survival after kidney transplantation"</a>.)</p><p>Analyses of the United States Renal Data Systems (USRDS) database have shown that pretransplant dialysis duration of six months or more is associated with decreased allograft survival [<a href="#rid2">2,15</a>]. In one study, dialysis duration for 36 months conferred a 68 percent increase in death-censored graft loss [<a href="#rid2">2</a>]. In another analysis, the 10-year adjusted graft survival for both deceased- and living-donor transplants was higher for patients transplanted preemptively compared with those who were on dialysis for two years prior to transplantation (69 and 75 for preemptive transplants versus 39 and 49 percent for dialysis followed by transplantation, respectively) [<a href="#rid16">16</a>]. </p><p>The risk of death with a functioning allograft and all-cause mortality is also higher among patients who are dialyzed for more than six months before transplantation [<a href="#rid2">2,15</a>]. Among patients older than 65 years who are on dialysis for four or more years, there is no survival advantage seen with living- or deceased-donor transplantation compared with dialysis [<a href="#rid17">17</a>].</p><p>Increased duration of dialysis prior to transplantation may increase the risk of cancer [<a href="#rid18">18</a>]. In one registry study, patients on dialysis for more than 4.5 years before transplantation had a 60 percent greater risk of cancer compared with those on dialysis for less than 1.5 years [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H3193941487"><span class="h1">DIALYSIS ISSUES</span></p><p class="headingAnchor" id="H810286544"><span class="h2">Before transplantation</span></p><p class="headingAnchor" id="H5"><span class="h3">Dialysis modality before transplantation</span><span class="headingEndMark"> — </span>Despite the associated risks, many patients need dialysis prior to transplantation.</p><p>Available dialysis modalities include hemodialysis, either in a dialysis center or at home, or peritoneal dialysis. There are no good, objective data to inform decisions regarding the choice of dialysis modality prior to transplantation. Practice patterns are center specific, and the choice of therapy is determined on a case-by-case basis, with consideration of patient preference and medical factors. The choice of modality generally depends on factors that are unrelated to transplantation; these include availability and convenience, comorbid conditions, socioeconomic and dialysis-center factors, and others [<a href="#rid19">19-25</a>]. (See  <a class="medical medical_review" href="/z/d/html/1844.html" rel="external">"Dialysis modality and patient outcome", section on 'Selection of dialysis modality'</a>.)</p><p>Most studies that have compared pretransplant dialysis modalities on posttransplant outcomes have shown no clear benefit of one modality over others on overall graft or patient survival [<a href="#rid26">26-37</a>]. A meta-analysis of 26 observational studies including 269,715 transplant recipients found no significant difference in the risk of all-cause mortality (hazard ratio [HR] 0.98, 95% CI 0.85-1.01), death-censored graft failure (HR 0.98, 95% CI 0.85-1.14), graft vessel thrombosis, or posttransplant diabetes mellitus between pretransplant peritoneal dialysis and pretransplant hemodialysis [<a href="#rid37">37</a>]. Pretransplant peritoneal dialysis was associated with a lower risk for overall graft failure (HR 0.96, 95% CI 0.92-0.99) and delayed graft function (HR 0.73, 95% CI 0.70-0.76), but the strength of the evidence was rated very low to low.</p><p class="headingAnchor" id="H260397680"><span class="h3">Routine dialysis immediately prior to transplantation</span><span class="headingEndMark"> — </span>For patients undergoing kidney transplant surgery, we suggest avoiding routine (ie, scheduled) dialysis in the 24 hours prior to transplantation. This recommendation differs from that for patients undergoing nontransplant surgery, for whom dialysis is generally recommended in the 24 hours prior to surgery. (See  <a class="medical medical_review" href="/z/d/html/1899.html" rel="external">"Medical management of the dialysis patient undergoing surgery", section on 'Routine dialysis prior to surgery'</a>.)</p><p>We avoid dialysis within 24 hours prior to transplantation because it may increase the risk of delayed graft function. The strong likelihood of kidney recovery after transplantation makes even small risks associated with dialysis less acceptable.</p><p>The effect of elective dialysis on short-term posttransplant outcomes is not certain [<a href="#rid38">38,39</a>]. One study suggested that dialysis within 24 hours of transplantation increased the risk of delayed graft function, especially if a bioincompatible filter was used and ultrafiltration was performed [<a href="#rid38">38</a>]. However, in a trial that randomly assigned 110 patients to receive hemodialysis (one three-hour session without ultrafiltration) or no hemodialysis immediately prior to transplantation, there was no difference in delayed graft function or estimated glomerular filtration rate (eGFR) five days posttransplant [<a href="#rid39">39</a>]. Thus, avoidance of ultrafiltration for 16 to 24 hours before transplantation may help to reduce the risk of delayed graft function.</p><p>In addition to a possible risk of delayed graft function, dialysis may contribute to electrolyte and fluid shifts, which require several hours to equilibrate, and could theoretically contribute to sudden death. Although not studied in the transplant perioperative period, in a retrospective study of 80 patients on chronic dialysis with documented sudden death, a 1.7-fold higher relative risk was observed in the 12-hour period beginning with the initiation of the dialysis treatment [<a href="#rid40">40</a>].</p><p>Among nontransplant patients with end-stage kidney disease (ESKD), this and other risks associated with dialysis are justified by the proven benefits provided by dialysis to patients with absent kidney function. By contrast, most patients undergoing transplantation have a rapid recovery of kidney function postoperatively. (See  <a class="medical medical_review" href="/z/d/html/1852.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury: Metabolic and hemodynamic considerations", section on 'Mechanisms of hemodialysis-induced hypotension'</a> and  <a class="medical medical_review" href="/z/d/html/1938.html" rel="external">"Dialysis-related factors that may influence recovery of kidney function in acute kidney injury (acute renal failure)"</a>.)</p><p class="headingAnchor" id="H614103797"><span class="h3">Indications for urgent dialysis before transplantation</span><span class="headingEndMark"> — </span>Despite the anticipated recovery of kidney function, dialysis may be indicated in some transplant candidates to correct metabolic abnormalities that cannot be treated conservatively or pose unacceptable anesthesia risk. As with patients on maintenance dialysis undergoing nontransplant surgery, the major indications for urgent dialysis before transplant surgery are hyperkalemia and volume overload. (See  <a class="medical medical_review" href="/z/d/html/1899.html" rel="external">"Medical management of the dialysis patient undergoing surgery", section on 'Indications for urgent preoperative dialysis'</a>.)</p><p>Hyperkalemia is the most common reason for dialysis in the immediate pretransplant period. Mild hyperkalemia at baseline is common among patients with chronic kidney disease (CKD) and may be exacerbated during surgery. In most cases, hyperkalemia resulting from transplant surgery is mild and readily managed conservatively. We generally dialyze patients who have a potassium &gt;5.4 mEq/L [<a href="#rid41">41</a>], but there is variability between centers. The threshold serum potassium at which it becomes unsafe to proceed with surgery without prior dialysis has not been evaluated among transplant patients, and there are no data that show that serum potassium should be normalized preoperatively [<a href="#rid42">42,43</a>]. (See  <a class="medical medical_review" href="/z/d/html/1899.html" rel="external">"Medical management of the dialysis patient undergoing surgery", section on 'Hyperkalemia'</a>.) </p><p>When dialysis is required, attention should be paid to the following dialysis prescription parameters:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ultrafiltration </strong>– Ultrafiltration (ie, fluid removal) should be avoided in most transplant candidates because there is evidence that fluid shifts are associated with delayed graft function, presumably due to the risk of inducing intravascular volume depletion with or without hypotension [<a href="#rid39">39</a>]. This may explain some of the observational data demonstrating lower delayed graft function in patients on peritoneal dialysis compared with patients on hemodialysis [<a href="#rid35">35</a>]. Some patients, however, require dialysis to treat volume overload. For such patients, we suggest using a relatively low rate of ultrafiltration (such as 5 to 10 mL/kg per hour), which allows for adequate plasma refill prior to surgery and may avoid intravascular volume depletion and hypotension during dialysis. Avoiding intravascular hypotension is particularly important because patients undergoing transplantation often receive intraoperative antibody preparations, which are associated with hypotension that could be exacerbated in a patient with recent, large ultrafiltration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysis session length </strong>– The length of the dialysis session should be tailored to the individual patient based on the preoperative goal of the treatment. Generally, hyperkalemia can be treated safely with two hours of dialysis without the need for a low-potassium bath. Patients who require ultrafiltration may require longer treatments (three to four hours) to remove volume safely and without inducing hypotension. Unlike patients who are not undergoing transplantation, urea kinetic modelling (ie, Kt/V) should not be used to direct treatment, since there is an anticipation of kidney recovery and no data correlating urea Kt/V with transplant outcomes. (See  <a class="medical medical_review" href="/z/d/html/1854.html" rel="external">"Acute hemodialysis prescription", section on 'Dialysis dose'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysate composition </strong>– The dialysate composition is the same as for nontransplant patients (see  <a class="medical medical_review" href="/z/d/html/1854.html" rel="external">"Acute hemodialysis prescription", section on 'Dialysate composition'</a>). However, the flux of calcium, magnesium, sodium, and glucose should be minimized during the treatment, and the choice of potassium and bicarbonate baths should be made carefully to minimize the development of hypokalemia and metabolic alkalosis. Dialysate temperature should also be tailored to each patient. We generally prefer a 3 mEq/L calcium, 1 mEq/L magnesium, 140 mEq/L constant sodium, and 100 mg/dL glucose dialysate bath. We adjust the dialysate temperature to typically be 0 to 1 degree Celsius below the patient's body temperature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anticoagulation </strong>– Most outpatient dialysis treatments are performed with systemic anticoagulation utilizing heparin. It is preferred not to use heparin among patients who are undergoing transplantation with 24 hours of dialysis. The expected half-life of the usual 10 to 50 international units/kg bolus dose of heparin with hemodialysis is approximately 30 to 90 minutes, which is longer in a patient with ESKD than in a patient without ESKD and variable depending upon other facets of the dialysis treatment. Intraperitoneal heparin occasionally utilized for fibrin in peritoneal dialysis does not produce systemic anticoagulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialyzer membrane </strong>– A biocompatible membrane should be used for all patients who are undergoing dialysis prior to transplantation. Complement-activating or bioincompatible membrane dialyzers (eg, cuprophane dialyzers) have been associated with delayed graft function. As an example, in a study of 44 allograft recipients who were dialyzed within 24 hours prior to transplantation, recovery of kidney function was higher among those dialyzed with biocompatible membranes compared with bioincompatible ones [<a href="#rid38">38</a>].</p><p></p><p class="headingAnchor" id="H1253548538"><span class="h2">After transplantation</span></p><p class="headingAnchor" id="H9"><span class="h3">Dialysis immediately after transplantation</span><span class="headingEndMark"> — </span>Approximately 20 percent of patients require temporary dialysis after transplantation [<a href="#rid44">44-46</a>]. The need for dialysis in the first postoperative week after transplantation is called delayed graft function, regardless of the cause of kidney dysfunction. Delayed graft function has been independently associated with nearly two- to threefold increases in patient death, graft failure, and death-censored graft failure [<a href="#rid35">35,45,47</a>]. The risk of delayed graft function may be assessed using a nomogram that has been evaluated in multiple studies [<a href="#rid44">44</a>].</p><p>The indications for acute dialysis among patients in the immediate transplant period are the same as among nontransplant patients who develop acute kidney injury. (See  <a class="medical medical_review" href="/z/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Urgent indications'</a>.)</p><p>The optimal dialysis modality in the postoperative period is not well studied. We, and most nephrologists, perform hemodialysis after transplantation. This is because of the concern that the peritoneal membrane has been disrupted during transplant surgery, with the potential for leakage of glucose-containing peritoneal dialysate fluid and infection [<a href="#rid48">48</a>]. Some authors have suggested removing the peritoneal dialysis catheter at the time of transplant surgery to avoid the approximately 5 percent or greater risk of peritonitis even in patients who do not perform dialysis [<a href="#rid49">49</a>]. However, peritoneal dialysis has been used successfully in some patients with delayed graft function [<a href="#rid50">50,51</a>], with some clinicians prescribing low-volume (approximately 15 mL/kg or less) supine exchanges [<a href="#rid52">52</a>]. Generally, there is no indication for continuous kidney replacement therapies. (See  <a class="medical medical_review" href="/z/d/html/1845.html" rel="external">"Continuous kidney replacement therapy in acute kidney injury"</a>.)</p><p>The dialysis prescription is generally the same as for nontransplantation patients. (See  <a class="medical medical_review" href="/z/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Intermittent hemodialysis'</a>.)</p><p>Excessive ultrafiltration should be avoided in order to limit the possibility of ischemic injury to the allograft. We generally target a weight (as a parameter of volume) that is within 1 to 2 kilograms of the patient's known dry weight with fluid removal not greater than 10 mL/kg/hour.</p><p class="headingAnchor" id="H3988030468"><span class="h3">Removal of peritoneal dialysis catheter</span><span class="headingEndMark"> — </span>The optimal timing of peritoneal dialysis catheter removal after kidney transplantation is unclear [<a href="#rid53">53</a>]. For living-donor recipients, most centers base the decision to remove the catheter during transplant surgery on the immediate status of the allograft after the kidney is reperfused. If the allograft demonstrates satisfactory perfusion and diuresis intraoperatively, transplant surgeons usually will remove the peritoneal dialysis catheter during the operation. For marginal allograft appearance and/or delayed diuresis, the peritoneal dialysis catheter remains in place in case peritoneal dialysis is necessary postoperatively. For deceased-donor recipients, the approach to catheter removal intraoperatively is more varied; for centers with higher rates of delayed graft function the catheter may be left in, even in cases in which adequate allograft perfusion and diuresis are observed.</p><p>Infrequently, the catheter is removed intraoperatively after inadvertent, large incisions in the peritoneum are made during the transplant procedure. Large peritoneal disruptions in this setting generally require at least a temporary transition from peritoneal dialysis to intermittent hemodialysis, should dialysis be required in the postoperative period.</p><p>Patients at high risk for peritonitis may benefit from earlier catheter removal. As an example, one retrospective study of 232 patients on peritoneal dialysis found that a significantly increased incidence of peritonitis occurred in those with the following clinical characteristics [<a href="#rid54">54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>An increased number of peritonitis episodes prior to surgery (median of three)</p><p class="bulletIndent1"><span class="glyph">●</span>Previous peritonitis episodes due to <em>Staphylococcus aureus</em></p><p class="bulletIndent1"><span class="glyph">●</span>Male sex</p><p class="bulletIndent1"><span class="glyph">●</span>Technical problems at surgery</p><p class="bulletIndent1"><span class="glyph">●</span>More than two rejection episodes</p><p class="bulletIndent1"><span class="glyph">●</span>Permanent graft nonfunction</p><p class="bulletIndent1"><span class="glyph">●</span>Urinary leak</p><p></p><p class="headingAnchor" id="H124132956"><span class="h3">Dialysis after graft failure</span><span class="headingEndMark"> — </span>Patients may require dialysis after their transplanted kidney has failed. This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7320.html" rel="external">"Kidney transplantation in adults: Management of the patient with a failed kidney transplant", section on 'Dialysis after graft failure'</a>.)</p><p class="headingAnchor" id="H2342419249"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110754.html" rel="external">"Society guideline links: Kidney transplantation"</a>.)</p><p class="headingAnchor" id="H33915669"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing of transplantation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients not on dialysis </strong>– For most patients with end-stage kidney disease (ESKD) who are suitable candidates for transplantation, we suggest preemptive transplantation rather than waiting until dialysis is initiated (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Preemptive transplantation is associated with improved graft and patient survival when compared with transplantation after a period of dialysis therapy. Exceptions to preemptive transplantation include patients who have severe, symptomatic nephrotic syndrome and those undergoing a second transplant after the first transplanted kidney failed within one year from transplantation. Such patients may benefit from a short period of dialysis prior to transplantation. (See <a class="local">'Preemptive transplantation'</a> above.) </p><p></p><p class="bulletIndent2">Transplantation should not be performed until the estimated glomerular filtration rate (eGFR) is &lt;20 mL/min/1.73 m<sup>2</sup> and evidence exists of a progressive and irreversible decrease in kidney function over the previous 6 to 12 months. (See <a class="local">'Glomerular filtration rate threshold for transplantation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients on dialysis </strong>– Patients who are already on dialysis and are suitable candidates for transplantation should be considered for transplantation as soon as possible. This is because the adverse effects of dialysis therapy on posttransplant outcomes are duration dependent. (See <a class="local">'Patients already on dialysis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysis issues before transplantation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Modality before transplantation </strong>–<strong> </strong>Most studies have found similar risks of mortality with peritoneal dialysis or hemodialysis prior to transplantation. The choice of modality generally depends on factors that are unrelated to transplantation; these include availability and convenience, comorbid conditions, and socioeconomic and dialysis-center factors. (See <a class="local">'Dialysis modality before transplantation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Routine dialysis prior to transplant </strong>– For patients undergoing kidney transplant surgery, we suggest avoiding routine (ie, scheduled) dialysis in the 24 hours prior to transplantation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). This recommendation differs from that for patients undergoing nontransplant surgery, for whom dialysis is generally recommended in the 24 hours prior to surgery. Dialysis within 24 hours prior to transplantation may increase the risk of delayed graft function. (See <a class="local">'Routine dialysis immediately prior to transplantation'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications for urgent dialysis </strong>– As with patients on maintenance dialysis undergoing nontransplant surgery, the major indications for urgent dialysis before transplant surgery are hyperkalemia and volume overload. (See <a class="local">'Indications for urgent dialysis before transplantation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysis issues after transplantation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dialysis immediately posttransplant </strong>– The need for dialysis in the first postoperative week after transplantation is called delayed graft function, regardless of the cause of kidney dysfunction. The indications for dialysis are the same for such patients as for nontransplant patients with acute kidney injury. Excessive ultrafiltration should be avoided, if possible, in order to limit the possibility of ischemic injury to the allograft. (See <a class="local">'Dialysis immediately after transplantation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Removal of the peritoneal dialysis catheter </strong>– The optimal timing of peritoneal dialysis catheter removal after kidney transplantation is unclear. For living-donor recipients, most centers base the decision to remove the catheter during transplant surgery on the immediate status of the allograft after the kidney is reperfused. If the allograft demonstrates satisfactory perfusion and diuresis intraoperatively, transplant surgeons usually will remove the peritoneal dialysis catheter during the operation. For marginal allograft appearance and/or delayed diuresis, the peritoneal dialysis catheter remains in place in case peritoneal dialysis is necessary postoperatively. For deceased-donor recipients, the approach to catheter removal intraoperatively is more varied; for centers with higher rates of delayed graft function the catheter may be left in, even in cases in which adequate allograft perfusion and diuresis are observed. (See <a class="local">'Removal of peritoneal dialysis catheter'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dialysis after graft failure </strong>– Patients may require dialysis after their transplanted kidney has failed. This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7320.html" rel="external">"Kidney transplantation in adults: Management of the patient with a failed kidney transplant", section on 'Dialysis after graft failure'</a>.)</p><p></p><p class="headingAnchor" id="H4081926243"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Vijaya Venkataraman, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kasiske BL, Snyder JJ, Matas AJ, et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13:1358.</a></li><li><a class="nounderline abstract_t">Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58:1311.</a></li><li><a class="nounderline abstract_t">Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344:726.</a></li><li><a class="nounderline abstract_t">Gill JS, Tonelli M, Johnson N, Pereira BJ. Why do preemptive kidney transplant recipients have an allograft survival advantage? Transplantation 2004; 78:873.</a></li><li><a class="nounderline abstract_t">Liem YS, Weimar W. Early living-donor kidney transplantation: a review of the associated survival benefit. Transplantation 2009; 87:317.</a></li><li><a class="nounderline abstract_t">Yoo SW, Kwon OJ, Kang CM. Preemptive living-donor renal transplantation: outcome and clinical advantages. Transplant Proc 2009; 41:117.</a></li><li><a class="nounderline abstract_t">Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005; 18:499.</a></li><li class="breakAll">Centers for Medicare &amp; Medicaid Services (CMS)/Center for Medicare and Medicaid Innovation (CMMI) Kidney Care Choices (KCC) Model. https://innovation.cms.gov/files/x/kcc-rfa.pdf (Accessed on November 13, 2020).</li><li class="breakAll">OPTN policy 3.5: Allocation of deceased kidneys. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_7.pdf (Accessed on July 25, 2013).</li><li><a class="nounderline abstract_t">Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173:1181.</a></li><li><a class="nounderline abstract_t">Akkina SK, Connaire JJ, Snyder JJ, et al. Earlier is not necessarily better in preemptive kidney transplantation. Am J Transplant 2008; 8:2071.</a></li><li><a class="nounderline abstract_t">Grams ME, Massie AB, Coresh J, Segev DL. Trends in the timing of pre-emptive kidney transplantation. J Am Soc Nephrol 2011; 22:1615.</a></li><li class="breakAll">FY 2020 state and national averages for the Dialysis Facility Reports. https://data.cms.gov/Medicare/FY-2020-State-and-National-Averages-for-the-Dialys/mb8z-3cxq (Accessed on November 09, 2020).</li><li class="breakAll">US Department of Health and Human Services, Health Resources and Services Administration, Organ Procurement and Transplantation Network, National data. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# (Accessed on February 12, 2023).</li><li><a class="nounderline abstract_t">Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20:167.</a></li><li><a class="nounderline abstract_t">Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74:1377.</a></li><li><a class="nounderline abstract_t">Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 2006; 1:532.</a></li><li><a class="nounderline abstract_t">Wong G, Turner RM, Chapman JR, et al. Time on dialysis and cancer risk after kidney transplantation. Transplantation 2013; 95:114.</a></li><li><a class="nounderline abstract_t">Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 2000; 20:375.</a></li><li><a class="nounderline abstract_t">Goldstein A, Kliger AS, Finkelstein FO. Recovery of renal function and the discontinuation of dialysis in patients treated with continuous peritoneal dialysis. Perit Dial Int 2003; 23:151.</a></li><li><a class="nounderline abstract_t">Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis 2003; 42:1082.</a></li><li><a class="nounderline abstract_t">Wauters JP, Uehlinger D. Non-medical factors influencing peritoneal dialysis utilization: the Swiss experience. Nephrol Dial Transplant 2004; 19:1363.</a></li><li><a class="nounderline abstract_t">Mendelssohn DC, Langlois N, Blake PG. Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology. Perit Dial Int 2004; 24:531.</a></li><li><a class="nounderline abstract_t">Tonelli M, Hemmelgarn B, Culleton B, et al. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int 2007; 72:1023.</a></li><li><a class="nounderline abstract_t">Mehrotra R, Khawar O, Duong U, et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am J Kidney Dis 2009; 54:289.</a></li><li><a class="nounderline abstract_t">Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000; 69:1414.</a></li><li><a class="nounderline abstract_t">Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998; 53:767.</a></li><li><a class="nounderline abstract_t">Binaut R, Hazzan M, Pruvot FR, et al. Comparative study of chronic ambulatory peritoneal dialysis versus hemodialysis patients after kidney transplantation: clinical and financial assessment. Transplant Proc 1997; 29:2428.</a></li><li><a class="nounderline abstract_t">Van Biesen W, Vanholder R, Van Loo A, et al. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation 2000; 69:508.</a></li><li><a class="nounderline abstract_t">Vanholder R, Heering P, Loo AV, et al. Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis. Am J Kidney Dis 1999; 33:934.</a></li><li><a class="nounderline abstract_t">Ojo AO, Hanson JA, Wolfe RA, et al. Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. Kidney Int 1999; 55:1952.</a></li><li><a class="nounderline abstract_t">Passalacqua JA, Wiland AM, Fink JC, et al. Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients. Transplantation 1999; 68:535.</a></li><li><a class="nounderline abstract_t">Chalem Y, Ryckelynck JP, Tuppin P, et al. Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France. Kidney Int 2005; 67:2448.</a></li><li><a class="nounderline abstract_t">Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, et al. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. Am J Kidney Dis 2005; 46:537.</a></li><li><a class="nounderline abstract_t">Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002; 62:1423.</a></li><li><a class="nounderline abstract_t">Inrig JK, Sun JL, Yang Q, et al. Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation. Clin J Am Soc Nephrol 2006; 1:774.</a></li><li><a class="nounderline abstract_t">Ngamvichchukorn T, Ruengorn C, Noppakun K, et al. Association Between Pretransplant Dialysis Modality and Kidney Transplant Outcomes: A Systematic Review and Meta-analysis. JAMA Netw Open 2022; 5:e2237580.</a></li><li><a class="nounderline abstract_t">Van Loo AA, Vanholder RC, Bernaert PR, et al. Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol 1998; 9:473.</a></li><li><a class="nounderline abstract_t">Kikić Z, Lorenz M, Sunder-Plassmann G, et al. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation 2009; 88:1377.</a></li><li><a class="nounderline abstract_t">Bleyer AJ, Hartman J, Brannon PC, et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69:2268.</a></li><li class="breakAll">Danovitch GM. Handbook of Kidney Transplantation, Lippincott Williams &amp; Wilkins, Philadelphia 2010. Vol 5.</li><li><a class="nounderline abstract_t">Palevsky PM. Perioperative management of patients with chronic kidney disease or ESRD. Best Pract Res Clin Anaesthesiol 2004; 18:129.</a></li><li><a class="nounderline abstract_t">Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 2008; 3:324.</a></li><li><a class="nounderline abstract_t">Irish WD, Ilsley JN, Schnitzler MA, et al. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10:2279.</a></li><li><a class="nounderline abstract_t">Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66:1697.</a></li><li><a class="nounderline abstract_t">Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14:2967.</a></li><li><a class="nounderline abstract_t">Tapiawala SN, Tinckam KJ, Cardella CJ, et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010; 21:153.</a></li><li><a class="nounderline abstract_t">Solak Y, Atalay H, Polat I, Yeksan M. CAPD-related peritonitis after renal transplantation. Perit Dial Int 2010; 30:596.</a></li><li><a class="nounderline abstract_t">Warren J, Jones E, Sener A, et al. Should peritoneal dialysis catheters be removed at the time of kidney transplantation? Can Urol Assoc J 2012; 6:376.</a></li><li><a class="nounderline abstract_t">Thomson BK, Moser MA, Marek C, et al. Peritoneal dialysis versus hemodialysis in patients with delayed graft function. Clin Transplant 2013; 27:E709.</a></li><li><a class="nounderline abstract_t">Rizzi AM, Riutta SD, Peterson JM, et al. Risk of peritoneal dialysis catheter-associated peritonitis following kidney transplant. Clin Transplant 2018; 32:e13189.</a></li><li><a class="nounderline abstract_t">Gardezi AI, Muth B, Ghaffar A, et al. Continuation of Peritoneal Dialysis in Adult Kidney Transplant Recipients With Delayed Graft Function. Kidney Int Rep 2021; 6:1634.</a></li><li><a class="nounderline abstract_t">Zawistowski M, Nowaczyk J, Domagała P. Peritoneal dialysis catheter removal at the time or after kidney transplantation: a systematic review and meta-analysis. Langenbecks Arch Surg 2022; 407:2651.</a></li><li><a class="nounderline abstract_t">Bakir N, Surachno S, Sluiter WJ, Struijk DG. Peritonitis in peritoneal dialysis patients after renal transplantation. Nephrol Dial Transplant 1998; 13:3178.</a></li></ol></div><div id="topicVersionRevision">Topic 7334 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11961024" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Preemptive kidney transplantation: the advantage and the advantaged.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10972695" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Effect of waiting time on renal transplant outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11236776" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15385807" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Why do preemptive kidney transplant recipients have an allograft survival advantage?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19202433" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Early living-donor kidney transplantation: a review of the associated survival benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19249492" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Preemptive living-donor renal transplantation: outcome and clinical advantages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16398713" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The impact of pretransplant dialysis on outcomes in renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16398713" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The impact of pretransplant dialysis on outcomes in renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16398713" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The impact of pretransplant dialysis on outcomes in renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16275969" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18782295" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Earlier is not necessarily better in preemptive kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617118" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Trends in the timing of pre-emptive kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617118" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Trends in the timing of pre-emptive kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617118" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Trends in the timing of pre-emptive kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15546892" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Duration of end-stage renal disease and kidney transplant outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12451234" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699256" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23222892" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Time on dialysis and cancer risk after kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11007366" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The role of peritoneal dialysis as the first-line renal replacement modality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12713082" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Recovery of renal function and the discontinuation of dialysis in patients treated with continuous peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14582053" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993480" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Non-medical factors influencing peritoneal dialysis utilization: the Swiss experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15559481" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17637709" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Mortality of Canadians treated by peritoneal dialysis in remote locations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19359081" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10798764" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9507225" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Patient survival after renal transplantation: I. The impact of dialysis pre-transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9270795" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Comparative study of chronic ambulatory peritoneal dialysis versus hemodialysis patients after kidney transplantation: clinical and financial assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10708103" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10213652" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10231459" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10480413" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15882291" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16129217" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12234315" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A comparison of transplant outcomes in peritoneal and hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699286" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36264575" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Association Between Pretransplant Dialysis Modality and Kidney Transplant Outcomes: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9513911" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pretransplantation hemodialysis strategy influences early renal graft function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20029334" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16672908" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Characteristics of sudden death in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16672908" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Characteristics of sudden death in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14760878" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Perioperative management of patients with chronic kidney disease or ESRD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18235147" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Retrospective review of the frequency of ECG changes in hyperkalemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20883559" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9884262" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14569108" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19875806" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Delayed graft function and the risk for death with a functioning graft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21148054" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : CAPD-related peritonitis after renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23093631" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Should peritoneal dialysis catheters be removed at the time of kidney transplantation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24138529" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Peritoneal dialysis versus hemodialysis in patients with delayed graft function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29292535" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Risk of peritoneal dialysis catheter-associated peritonitis following kidney transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34169204" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Continuation of Peritoneal Dialysis in Adult Kidney Transplant Recipients With Delayed Graft Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35945300" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Peritoneal dialysis catheter removal at the time or after kidney transplantation: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9870485" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Peritonitis in peritoneal dialysis patients after renal transplantation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
